Michael Yee Score: 44
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+8.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
64%
34 W / 19 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
74%
25 W / 9 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
24%
8 W / 26 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
15%
5 W / 29 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
60%
18 W / 12 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
61%
30 W / 19 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
4 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 09, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$175.00
Est. +18%
|
$148.45 | $193.74 |
Target Met
|
$189.23
+27.5%
|
| May 27, 2026 |
Pfizer Inc.
PFE
|
BUY |
$27.00
Est. +2%
|
$26.35 | $26.54 |
Precision Hit (±3%)
|
$24.54
-6.9%
|
| Mar 06, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$70.00
Est. +17%
|
$59.79 | $62.82 |
Pending
|
$62.09
+3.8%
|
| Feb 24, 2026 |
Arcellx Inc
ACLX
|
BUY |
$115.00
Est. +1%
|
$113.75 | $115.13 |
Bullseye Hit (±1%)
|
$115.07
+1.2%
|
| Jan 08, 2026 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$14.00
Est. +2%
|
$13.73 | $14.07 |
Bullseye Hit (±1%)
|
$14.00
+2.0%
|
| Jan 07, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$145.00
Est. +19%
|
$121.36 | $157.27 |
Target Met
|
$129.31
+6.6%
|
| Jan 07, 2026 |
Kodiak Sciences Inc
KOD
|
BUY |
$50.00
Est. +100%
|
$25.05 | $47.84 |
Pending
|
$41.41
+65.3%
|
| Jan 07, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$70.00
Est. +59%
|
$43.91 | $72.27 |
Target Met
|
$54.15
+23.3%
|
| Jan 07, 2026 |
Inventiva - ADR
IVA
|
BUY |
$12.00
Est. +164%
|
$4.54 | $7.29 |
Pending
|
$4.46
-1.8%
|
| Jan 07, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$60.00
Est. +109%
|
$28.70 | $66.66 |
Target Met
|
$62.00
+116.0%
|
| Jan 07, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$50.00
Est. +88%
|
$26.62 | $97.78 |
Target Met
|
$92.16
+246.2%
|
| Jan 07, 2026 |
Arcellx Inc
ACLX
|
BUY |
$100.00
Est. +61%
|
$62.06 | $115.13 |
Target Met
|
$115.07
+85.4%
|
| Jan 07, 2026 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$45.00
Est. +80%
|
$25.04 | $29.50 |
Pending
|
$11.70
-53.3%
|
| Jan 07, 2026 |
Beam Therapeutics Inc
BEAM
|
SELL |
$28.00
Est. +1%
|
$28.34 | $21.63 (Low) |
Target Met
|
$25.10
+11.4%
|
| Jan 07, 2026 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$10.00
Est. +18%
|
$8.49 | $9.10 |
Pending
|
$6.42
-24.4%
|
| Jan 07, 2026 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$55.00
Est. +67%
|
$32.85 | $36.26 |
Pending
|
$35.00
+6.5%
|
| Jan 07, 2026 |
SAB Biotherapeutics Inc
SABS
|
BUY |
$7.00
Est. +93%
|
$3.62 | $5.15 |
Pending
|
$3.51
-3.0%
|
| Jan 07, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$60.00
Est. +45%
|
$41.31 | $58.49 |
Precision Hit (±3%)
|
$47.67
+15.4%
|
| Jan 07, 2026 |
Cogent Biosciences Inc
COGT
|
BUY |
$60.00
Est. +73%
|
$34.78 | $41.35 |
Pending
|
$39.76
+14.3%
|
| Jan 07, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$25.00
Est. +45%
|
$17.21 | $27.30 |
Target Met
|
$23.11
+34.3%
|
| Jan 07, 2026 |
Aligos Therapeutics Inc
ALGS
|
BUY |
$20.00
Est. +128%
|
$8.76 | $10.49 |
Pending
|
$4.08
-53.4%
|
| Jan 07, 2026 |
Schrodinger Inc
SDGR
|
SELL |
$18.00
Est. +4%
|
$18.79 | $10.95 (Low) |
Target Met
|
$14.97
+20.3%
|
| Jan 06, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,250.00
Est. +17%
|
$1,064.04 | $1,249.45 |
Bullseye Hit (±1%)
|
$1,196.04
+12.4%
|
| Jan 06, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$535.00
Est. +14%
|
$468.38 | $533.67 |
Bullseye Hit (±1%)
|
$477.32
+1.9%
|
| Dec 10, 2025 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$43.00
Est. +40%
|
$30.66 | $36.26 |
Pending
|
$11.70
-61.8%
|
| Dec 09, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$550.00
Est. +19%
|
$462.10 | $519.68 |
Miss
|
$477.32
+3.3%
|
| Dec 09, 2024 |
Biogen Inc
BIIB
|
BUY |
$180.00
Est. +14%
|
$157.78 | $185.17 |
Precision Hit (±3%)
|
$202.19
+28.1%
|
| Dec 09, 2024 |
Kodiak Sciences Inc
KOD
|
BUY |
$20.00
Est. +74%
|
$11.48 | $26.19 |
Target Met
|
$41.41
+260.7%
|
| Nov 12, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$380.00
Est. +27%
|
$298.84 | $342.40 |
Miss
|
$376.04
+25.8%
|
| Nov 01, 2024 |
Denali Therapeutics Inc
DNLI
|
BUY |
$45.00
Est. +66%
|
$27.05 | $33.32 |
Miss
|
$23.11
-14.6%
|
| Oct 14, 2024 |
Moderna Inc
MRNA
|
SELL |
$55.00
Est. +5%
|
$57.73 | $23.15 (Low) |
Target Met
|
$54.05
+6.4%
|
| Sep 23, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$95.00
Est. +13%
|
$83.76 | $121.83 |
Target Met
|
$129.31
+54.4%
|
| Sep 12, 2024 |
Moderna Inc
MRNA
|
BUY |
$120.00
Est. +78%
|
$67.52 | $75.36 |
Miss
|
$54.05
-19.9%
|
| Sep 12, 2024 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$40.00
Est. +54%
|
$26.00 | $16.88 |
Miss
|
$92.16
+254.5%
|
| Sep 12, 2024 |
Moderna Inc
MRNA
|
SELL |
$65.00
Est. +7%
|
$69.68 | $23.15 (Low) |
Target Met
|
$54.05
+22.4%
|
| Jul 13, 2024 |
Morphic Holding Inc
MORF
|
BUY |
$57.00
Est. +2%
|
$55.78 | $57.00 |
Bullseye Hit (±1%)
|
$56.99
+2.2%
|
| Jun 24, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$85.00
Est. +19%
|
$71.24 | $119.69 |
Target Met
|
$129.31
+81.5%
|
| Jun 07, 2024 |
Moderna Inc
MRNA
|
BUY |
$180.00
Est. +18%
|
$152.03 | $129.36 |
Miss
|
$54.05
-64.4%
|
| May 03, 2024 |
Moderna Inc
MRNA
|
BUY |
$155.00
Est. +26%
|
$123.02 | $129.36 |
Miss
|
$54.05
-56.1%
|
| Mar 28, 2024 |
Moderna Inc
MRNA
|
BUY |
$125.00
Est. +13%
|
$110.59 | $129.36 |
Target Met
|
$54.05
-51.1%
|
| Mar 27, 2024 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$10.00
Est. +247%
|
$2.88 | $3.96 |
Miss
|
$6.42
+122.9%
|
| Mar 15, 2024 |
Immuneering Corp - Ordinary Shares Class A
IMRX
|
BUY |
$3.00
Est. +57%
|
$1.91 | $3.83 |
Target Met
|
$4.32
+126.2%
|
| Mar 13, 2024 |
Morphic Holding Inc
MORF
|
BUY |
$60.00
Est. +73%
|
$34.60 | $57.00 |
Miss
|
$56.99
+64.7%
|
| Sep 13, 2023 |
AMGEN Inc.
AMGN
|
BUY |
$310.00
Est. +19%
|
$260.31 | $346.85 |
Target Met
|
$376.04
+44.5%
|
| Sep 13, 2022 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$60.00
Est. +57%
|
$38.11 | - | - |
$14.00
-63.3%
|
| Sep 09, 2022 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$68.00
Est. +54%
|
$44.03 | - | - |
$35.00
-20.5%
|
| Apr 07, 2022 |
Biogen Inc
BIIB
|
BUY |
$300.00
Est. +42%
|
$211.64 | - | - |
$202.19
-4.5%
|
| Mar 01, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$80.00
Est. +34%
|
$59.50 | - | - |
$129.31
+117.3%
|
| Feb 27, 2022 |
Moderna Inc
MRNA
|
BUY |
$170.00
Est. +12%
|
$151.33 | - | - |
$54.05
-64.3%
|
| Jan 27, 2022 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$275.00
Est. +20%
|
$228.22 | - | - |
$477.32
+109.1%
|
| Jan 16, 2022 |
Biogen Inc
BIIB
|
BUY |
$325.00
Est. +36%
|
$239.30 | - | - |
$202.19
-15.5%
|
| Oct 25, 2021 |
Fate Therapeutics Inc
FATE
|
BUY |
$145.00
Est. +149%
|
$58.16 | - | - |
$2.41
-95.9%
|
| Oct 15, 2021 |
Intercept Pharmaceuticals Inc
ICPT
|
BUY |
$19.00
Est. +13%
|
$16.82 | - | - |
$19.00
+13.0%
|
Revolution Medicines Inc
RVMD
Jun 09, 2026
Signal & Target
BUY
$175.00
Start Price
$148.45
Best Price (1Y)
$193.74
Current Price
$189.23
Return
+27.5%
Pfizer Inc.
PFE
May 27, 2026
Signal & Target
BUY
$27.00
Start Price
$26.35
Best Price (1Y)
$26.54
Current Price
$24.54
Return
-6.9%
Bristol-Myers Squibb Co.
BMY
Mar 06, 2026
Signal & Target
BUY
$70.00
Start Price
$59.79
Best Price (1Y)
$62.82
Current Price
$62.09
Return
+3.8%
Arcellx Inc
ACLX
Feb 24, 2026
Signal & Target
BUY
$115.00
Start Price
$113.75
Best Price (1Y)
$115.13
Current Price
$115.07
Return
+1.2%
Ventyx Biosciences Inc
VTYX
Jan 08, 2026
Signal & Target
BUY
$14.00
Start Price
$13.73
Best Price (1Y)
$14.07
Current Price
$14.00
Return
+2.0%
Gilead Sciences, Inc.
GILD
Jan 07, 2026
Signal & Target
BUY
$145.00
Start Price
$121.36
Best Price (1Y)
$157.27
Current Price
$129.31
Return
+6.6%
Kodiak Sciences Inc
KOD
Jan 07, 2026
Signal & Target
BUY
$50.00
Start Price
$25.05
Best Price (1Y)
$47.84
Current Price
$41.41
Return
+65.3%
AnaptysBio Inc
ANAB
Jan 07, 2026
Signal & Target
BUY
$70.00
Start Price
$43.91
Best Price (1Y)
$72.27
Current Price
$54.15
Return
+23.3%
Inventiva - ADR
IVA
Jan 07, 2026
Signal & Target
BUY
$12.00
Start Price
$4.54
Best Price (1Y)
$7.29
Current Price
$4.46
Return
-1.8%
MBX Biosciences, Inc. Common Stock
MBX
Jan 07, 2026
Signal & Target
BUY
$60.00
Start Price
$28.70
Best Price (1Y)
$66.66
Current Price
$62.00
Return
+116.0%
Oruka Therapeutics, Inc.
ORKA
Jan 07, 2026
Signal & Target
BUY
$50.00
Start Price
$26.62
Best Price (1Y)
$97.78
Current Price
$92.16
Return
+246.2%
Arcellx Inc
ACLX
Jan 07, 2026
Signal & Target
BUY
$100.00
Start Price
$62.06
Best Price (1Y)
$115.13
Current Price
$115.07
Return
+85.4%
Olema Pharmaceuticals Inc
OLMA
Jan 07, 2026
Signal & Target
BUY
$45.00
Start Price
$25.04
Best Price (1Y)
$29.50
Current Price
$11.70
Return
-53.3%
Beam Therapeutics Inc
BEAM
Jan 07, 2026
Signal & Target
SELL
$28.00
Start Price
$28.34
Best Price (1Y)
$21.63
Current Price
$25.10
Return
+11.4%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Jan 07, 2026
Signal & Target
BUY
$10.00
Start Price
$8.49
Best Price (1Y)
$9.10
Current Price
$6.42
Return
-24.4%
Immunocore Holdings plc - ADR
IMCR
Jan 07, 2026
Signal & Target
BUY
$55.00
Start Price
$32.85
Best Price (1Y)
$36.26
Current Price
$35.00
Return
+6.5%
SAB Biotherapeutics Inc
SABS
Jan 07, 2026
Signal & Target
BUY
$7.00
Start Price
$3.62
Best Price (1Y)
$5.15
Current Price
$3.51
Return
-3.0%
Scholar Rock Holding Corp
SRRK
Jan 07, 2026
Signal & Target
BUY
$60.00
Start Price
$41.31
Best Price (1Y)
$58.49
Current Price
$47.67
Return
+15.4%
Cogent Biosciences Inc
COGT
Jan 07, 2026
Signal & Target
BUY
$60.00
Start Price
$34.78
Best Price (1Y)
$41.35
Current Price
$39.76
Return
+14.3%
Denali Therapeutics Inc
DNLI
Jan 07, 2026
Signal & Target
BUY
$25.00
Start Price
$17.21
Best Price (1Y)
$27.30
Current Price
$23.11
Return
+34.3%
Aligos Therapeutics Inc
ALGS
Jan 07, 2026
Signal & Target
BUY
$20.00
Start Price
$8.76
Best Price (1Y)
$10.49
Current Price
$4.08
Return
-53.4%
Schrodinger Inc
SDGR
Jan 07, 2026
Signal & Target
SELL
$18.00
Start Price
$18.79
Best Price (1Y)
$10.95
Current Price
$14.97
Return
+20.3%
Lilly(Eli) & Co
LLY
Jan 06, 2026
Signal & Target
BUY
$1,250.00
Start Price
$1,064.04
Best Price (1Y)
$1,249.45
Current Price
$1,196.04
Return
+12.4%
Vertex Pharmaceuticals, Inc.
VRTX
Jan 06, 2026
Signal & Target
BUY
$535.00
Start Price
$468.38
Best Price (1Y)
$533.67
Current Price
$477.32
Return
+1.9%
Olema Pharmaceuticals Inc
OLMA
Dec 10, 2025
Signal & Target
BUY
$43.00
Start Price
$30.66
Best Price (1Y)
$36.26
Current Price
$11.70
Return
-61.8%
Vertex Pharmaceuticals, Inc.
VRTX
Dec 09, 2024
Signal & Target
BUY
$550.00
Start Price
$462.10
Best Price (1Y)
$519.68
Current Price
$477.32
Return
+3.3%
Biogen Inc
BIIB
Dec 09, 2024
Signal & Target
BUY
$180.00
Start Price
$157.78
Best Price (1Y)
$185.17
Current Price
$202.19
Return
+28.1%
Kodiak Sciences Inc
KOD
Dec 09, 2024
Signal & Target
BUY
$20.00
Start Price
$11.48
Best Price (1Y)
$26.19
Current Price
$41.41
Return
+260.7%
AMGEN Inc.
AMGN
Nov 12, 2024
Signal & Target
BUY
$380.00
Start Price
$298.84
Best Price (1Y)
$342.40
Current Price
$376.04
Return
+25.8%
Denali Therapeutics Inc
DNLI
Nov 01, 2024
Signal & Target
BUY
$45.00
Start Price
$27.05
Best Price (1Y)
$33.32
Current Price
$23.11
Return
-14.6%
Moderna Inc
MRNA
Oct 14, 2024
Signal & Target
SELL
$55.00
Start Price
$57.73
Best Price (1Y)
$23.15
Current Price
$54.05
Return
+6.4%
Gilead Sciences, Inc.
GILD
Sep 23, 2024
Signal & Target
BUY
$95.00
Start Price
$83.76
Best Price (1Y)
$121.83
Current Price
$129.31
Return
+54.4%
Moderna Inc
MRNA
Sep 12, 2024
Signal & Target
BUY
$120.00
Start Price
$67.52
Best Price (1Y)
$75.36
Current Price
$54.05
Return
-19.9%
Oruka Therapeutics, Inc.
ORKA
Sep 12, 2024
Signal & Target
BUY
$40.00
Start Price
$26.00
Best Price (1Y)
$16.88
Current Price
$92.16
Return
+254.5%
Moderna Inc
MRNA
Sep 12, 2024
Signal & Target
SELL
$65.00
Start Price
$69.68
Best Price (1Y)
$23.15
Current Price
$54.05
Return
+22.4%
Morphic Holding Inc
MORF
Jul 13, 2024
Signal & Target
BUY
$57.00
Start Price
$55.78
Best Price (1Y)
$57.00
Current Price
$56.99
Return
+2.2%
Gilead Sciences, Inc.
GILD
Jun 24, 2024
Signal & Target
BUY
$85.00
Start Price
$71.24
Best Price (1Y)
$119.69
Current Price
$129.31
Return
+81.5%
Moderna Inc
MRNA
Jun 07, 2024
Signal & Target
BUY
$180.00
Start Price
$152.03
Best Price (1Y)
$129.36
Current Price
$54.05
Return
-64.4%
Moderna Inc
MRNA
May 03, 2024
Signal & Target
BUY
$155.00
Start Price
$123.02
Best Price (1Y)
$129.36
Current Price
$54.05
Return
-56.1%
Moderna Inc
MRNA
Mar 28, 2024
Signal & Target
BUY
$125.00
Start Price
$110.59
Best Price (1Y)
$129.36
Current Price
$54.05
Return
-51.1%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Mar 27, 2024
Signal & Target
BUY
$10.00
Start Price
$2.88
Best Price (1Y)
$3.96
Current Price
$6.42
Return
+122.9%
Immuneering Corp - Ordinary Shares Class A
IMRX
Mar 15, 2024
Signal & Target
BUY
$3.00
Start Price
$1.91
Best Price (1Y)
$3.83
Current Price
$4.32
Return
+126.2%
Morphic Holding Inc
MORF
Mar 13, 2024
Signal & Target
BUY
$60.00
Start Price
$34.60
Best Price (1Y)
$57.00
Current Price
$56.99
Return
+64.7%
AMGEN Inc.
AMGN
Sep 13, 2023
Signal & Target
BUY
$310.00
Start Price
$260.31
Best Price (1Y)
$346.85
Current Price
$376.04
Return
+44.5%
Ventyx Biosciences Inc
VTYX
Sep 13, 2022
Signal & Target
BUY
$60.00
Start Price
$38.11
Best Price (1Y)
-
Current Price
$14.00
Return
-63.3%
Immunocore Holdings plc - ADR
IMCR
Sep 09, 2022
Signal & Target
BUY
$68.00
Start Price
$44.03
Best Price (1Y)
-
Current Price
$35.00
Return
-20.5%
Biogen Inc
BIIB
Apr 07, 2022
Signal & Target
BUY
$300.00
Start Price
$211.64
Best Price (1Y)
-
Current Price
$202.19
Return
-4.5%
Gilead Sciences, Inc.
GILD
Mar 01, 2022
Signal & Target
BUY
$80.00
Start Price
$59.50
Best Price (1Y)
-
Current Price
$129.31
Return
+117.3%
Moderna Inc
MRNA
Feb 27, 2022
Signal & Target
BUY
$170.00
Start Price
$151.33
Best Price (1Y)
-
Current Price
$54.05
Return
-64.3%
Vertex Pharmaceuticals, Inc.
VRTX
Jan 27, 2022
Signal & Target
BUY
$275.00
Start Price
$228.22
Best Price (1Y)
-
Current Price
$477.32
Return
+109.1%
Biogen Inc
BIIB
Jan 16, 2022
Signal & Target
BUY
$325.00
Start Price
$239.30
Best Price (1Y)
-
Current Price
$202.19
Return
-15.5%
Fate Therapeutics Inc
FATE
Oct 25, 2021
Signal & Target
BUY
$145.00
Start Price
$58.16
Best Price (1Y)
-
Current Price
$2.41
Return
-95.9%
Intercept Pharmaceuticals Inc
ICPT
Oct 15, 2021
Signal & Target
BUY
$19.00
Start Price
$16.82
Best Price (1Y)
-
Current Price
$19.00
Return
+13.0%